MedPath

The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study

Not Applicable
Completed
Conditions
Heart Failure
Interventions
Other: Telephone Call
Other: In-Person Primary Care Clinical Follow-Up Visit
Registration Number
NCT03524534
Lead Sponsor
Kaiser Permanente
Brief Summary

This study is a pragmatic randomized clinical trial to determine the effectiveness of two strategies of early follow-up in adults after hospitalization for heart failure: telephone follow-up with a heart failure care manager vs. in-person clinic visit with their primary care provider. The primary outcomes during 30-day follow-up will include readmission for heart failure, death and readmission for any cause. The study team aims to randomly assign 2400 patients during a 15-month period in a 1-to-1 ratio to either an initial structured telephone call with a heart failure care manager or an in-person primary care clinic visit within 7 days of discharge. A secondary goal is to increase the rate of any follow-up within 7 days of discharge to greater than 90 percent among all eligible patients.

Detailed Description

Heart failure (HF) affects \>5 million adults nationally and is the leading cause of hospitalization among Medicare beneficiaries. Reducing hospitalization for heart failure (HF) and subsequent readmissions shortly after discharge is a nationally recognized health care delivery system priority. More than 20% of Medicare patients hospitalized for HF are readmitted within 30 days and this rate has not been declining over the past decade despite increasing attention to this problem. The data that will be collected could allow the study team to tailor the post-discharge follow-up program to patient characteristics to further improve the effectiveness of the interventions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2091
Inclusion Criteria
  • All eligible patients hospitalized for confirmed acute heart failure at a Kaiser Permanente Northern California medical center
Exclusion Criteria
  • Planned discharge to a location other than their home. This includes a skilled nursing facility, nursing home or hospice facility.
  • Planned discharge to home with hospice care.
  • End-stage renal disease treated with chronic peritoneal dialysis or hemodialysis.
  • Death during the index hospitalization.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Telephone Follow-Up InterventionTelephone Call-
In-person follow-up interventionIn-Person Primary Care Clinical Follow-Up Visit-
Primary Outcome Measures
NameTimeMethod
Readmission for heart failure within 30-days30 days after discharge

To compare 30-day rates of heart failure-related readmission for subjects randomly assigned to initial heart failure care manager telephone visit vs. in-person primary care clinic visit within 7 days after discharge from a heart failure hospitalization.

Secondary Outcome Measures
NameTimeMethod
Readmission for any cause within 30 days30 days after discharge

To compare 30-day rates of readmission for any cause for subjects randomly assigned to initial heart failure care manager telephone visit vs. in-person primary care clinic visit within 7 days after discharge from a heart failure hospitalization.

Death from any cause within 30 days30 days after discharge

To compare 30-day rates of death from any cause for subjects randomly assigned to initial heart failure care manager telephone visit vs. in-person primary care clinic visit within 7 days after discharge from a heart failure hospitalization.

Increase in 7-day follow-up rates7 days after discharge

To increase follow-up rate within 7 days of discharge to \> 90% in eligible patients

© Copyright 2025. All Rights Reserved by MedPath